Celldex Therapeutics Inc (CLDX)
26.22
-0.18
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
26.24
+0.02
(+0.08%)
After-Hours: 20:00
Celldex Therapeutics Enterprise Value: 983.55M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 983.55M |
| November 20, 2024 | 995.49M |
| November 19, 2024 | 901.28M |
| November 18, 2024 | 790.48M |
| November 15, 2024 | 806.41M |
| November 14, 2024 | 951.70M |
| November 13, 2024 | 1.025B |
| November 12, 2024 | 1.036B |
| November 11, 2024 | 982.88M |
| November 08, 2024 | 983.55M |
| November 07, 2024 | 1.000B |
| November 06, 2024 | 1.077B |
| November 05, 2024 | 931.13M |
| November 04, 2024 | 928.48M |
| November 01, 2024 | 947.72M |
| October 31, 2024 | 972.93M |
| October 30, 2024 | 990.84M |
| October 29, 2024 | 1.026B |
| October 28, 2024 | 1.100B |
| October 25, 2024 | 1.032B |
| October 24, 2024 | 1.110B |
| October 23, 2024 | 1.146B |
| October 22, 2024 | 1.152B |
| October 21, 2024 | 1.147B |
| October 18, 2024 | 1.118B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.151B |
| October 16, 2024 | 1.216B |
| October 15, 2024 | 1.195B |
| October 14, 2024 | 1.253B |
| October 11, 2024 | 1.322B |
| October 10, 2024 | 1.213B |
| October 09, 2024 | 1.240B |
| October 08, 2024 | 1.271B |
| October 07, 2024 | 1.262B |
| October 04, 2024 | 1.277B |
| October 03, 2024 | 1.290B |
| October 02, 2024 | 1.248B |
| October 01, 2024 | 1.394B |
| September 30, 2024 | 1.499B |
| September 27, 2024 | 1.398B |
| September 26, 2024 | 1.376B |
| September 25, 2024 | 1.585B |
| September 24, 2024 | 1.913B |
| September 23, 2024 | 1.860B |
| September 20, 2024 | 1.931B |
| September 19, 2024 | 1.926B |
| September 18, 2024 | 1.972B |
| September 17, 2024 | 1.931B |
| September 16, 2024 | 2.039B |
| September 13, 2024 | 2.125B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-37.14M
Minimum
Mar 20 2020
2.862B
Maximum
Mar 05 2024
1.107B
Average
1.147B
Median
Oct 21 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Senseonics Holdings Inc | 170.58M |
| Myomo Inc | 138.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -42.12M |
| Revenue (Quarterly) | 3.191M |
| Total Expenses (Quarterly) | 55.32M |
| EPS Diluted (Quarterly) | -0.64 |
| Profit Margin (Quarterly) | -1.32K% |
| Earnings Yield | -9.84% |
| Normalized Earnings Yield | -10.93 |